MINDFULNESS-based stress reduction (MBSR) could match the effectiveness of the commonly prescribed antidepressant escitalopram in treating anxiety disorders, according to the latest psychological stress news. A recently published randomized clinical trial, involving 276 adults with diagnosed anxiety disorders, presents a promising alternative to pharmacological treatment for patients who prefer non-medication options or have medication sensitivities.
The study compared outcomes in two groups: one receiving MBSR, a structured 8-week program that includes mindfulness meditation and body awareness exercises, and another taking escitalopram. The findings show that both groups reported similar reductions in anxiety symptoms by the end of the trial, as measured by the Generalized Anxiety Disorder Scale-7 (GAD-7), a widely used tool for assessing anxiety. Both treatment approaches were similarly effective, with no statistically significant differences in results between the groups.
The trial’s lead researcher, Dr. Elizabeth Hoge from Georgetown University Medical Center, highlights the potential impact for patients who might not respond well to medication. “This study provides evidence that MBSR is as effective as first-line medication for anxiety and could be a viable alternative,” she notes. Importantly, mindfulness meditation practices have minimal side effects, whereas escitalopram is associated with potential adverse reactions like fatigue, nausea, and sexual dysfunction.
These findings underscore the value of including non-drug interventions in treatment plans for anxiety, especially for patients interested in mind-body approaches. While MBSR might not replace medication for all patients, it offers a compelling alternative or complementary option, particularly for those experiencing side effects or seeking a holistic approach to managing anxiety.
Reference: Hu H et al. Mindfulness meditation vs escitalopram for treatment of anxiety disorders: secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7(10):e2438453.
Anaya Malik | AMJ
